REFERENCES
- Barbosa D, Lima L, Silbert S, Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant enterococcus among patients on dialysis. Am J Kidney Dis. 2004;44(2):337–343.
- Troidle L, Kliger AS, Gorban-Brennan N, Fikrig M, Golden M, Finkelstein FO. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int. 1996; 50(4):1368–1372.
- Bailey EM, Faber MD, Nafziger DA. Linezolid for treatment of vancomycin-resistant enterococcal peritonitis. Am J Kidney Dis. 2001;38(4):1–3.
- Huen SC, Hall I, Topal J, Mahnensmith RL, Brewster UC, Abu-Alfa AK. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis. Am J Kidney Dis. 2009;54(3):538–541.
- Yildirim M, Sencan I, Ozdemir D, Oksüz S, Yilmaz Z, Sahin I. Vancomycin and high-level aminoglycoside resistant enterococcus carriage and the risk factors related to resistance in hospitalized patients. Mikrobiyol Bul. 2007;41(2):271–277.
- Piraino B, Bailie GR, Bernardini J, ISPD guidelines/recommendations. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–131.